Appendix H - Australian Sports Drug Medical Advisory Committee - functions

Following is an excerpt from the ASADA regulations describing the functions
of the Australian Sports Drug Medical Advisory Committee (ASDMAC).

Section 92 Functions of ASDMAC

1. The ASDMAC may investigate an adverse analytical finding for a sample given
by an athlete to find out whether the result was caused by naturally occurring levels of the substance concerned.

2. The ASDMAC may give an athlete approval, in accordance with the International standard for therapeutic use exemptions, as amended and in force from time
to time, to use a drug or doping method for therapeutic purposes.

3. If an athlete has an approval for the use of a drug for therapeutic purposes, the ASDMAC may investigate the sample analysis result for a sample given by the athlete to find out whether the athlete has complied with the conditions of the approval.

4. The ASDMAC may disclose to an athlete or support person:

  • a) information arising out of the entry of the name of the athlete or support person on the ASADA Register of Findings
  • b) information about a test on a sample given by the athlete:
  • I. carried out by a sporting administration body other than at the request of ASADA
  • II. that has revealed the presence of a drug or doping method.

5. The ASDMAC may disclose to any relevant sporting administration body:

a) information arising out of the entry of name of an athlete or support person on the ASADA Register of Findings information about a test on an athlete's sample:

I. carried out by a sporting administration body other than at the request of ASADA

II. that has revealed the presence of a drug or doping method.

6. If ASADA asks the ASDMAC to review the procedures adopted by a sporting administration body for approving the use of a drug or doping method for therapeutic purposes, the ASDMAC may do so.

7. If ASADA consults with the ASDMAC in relation to whether an approval for the use
of a drug for therapeutic purposes counts, the ASDMAC may investigate the approval and give its opinion to ASADA.

8. The ASDMAC may participate in a review or an appeal that is related directly
or indirectly to a decision made by the ASDMAC:

  • a) to approve the use of a drug for therapeutic purposes
  • b) to refuse to approve the use of a drug for therapeutic purposes.

9. The ASDMAC may give information to a sporting administration body that:

  • a) is related to a drug testing program
  • b) is related directly or indirectly to a decision made by the ASDMAC:
  • I. to approve the use of a drug for therapeutic purposes
  • II. to refuse to approve the use of a drug for therapeutic purposes.

10. However, the ASDMAC must not give information under subclause (9) unless the ASDMAC has taken reasonable steps to satisfy itself that the information disclosed will not be used or disclosed for other purposes.

Top of page